The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma
Open accessAbstract
Summary Diffuse intrinsic pontine glioma (DIPG) is a fatal pediatric cancer with limited therapeutic options. The majority of cases of DIPG exhibit a mutation in histone-3 (H3K27M) that results in oncogenic transcriptional aberrancies. We show here that DIPG is vulnerable to transcriptional disruption using bromodomain inhibition or CDK7 blockade. Targeting oncogenic transcription through either of these methods synergizes with HDAC inhibition and DIPG cells resistant to HDAC inhibitor therapy retain sensitivity to CDK7 blockade. Identification of super-enhancers in DIPG provides insights toward the cell of origin, highlighting oligodendroglial lineage genes, and reveals unexpected mechanisms mediating tumor viability and invasion, including potassium channel function and EPH receptor signaling. The findings presented demonstrate transcriptional vulnerabilities and elucidate previously unknown mechanisms of DIPG pathobiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
GREAT improves functional interpretation of cis-regulatory regions
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., & Bejerano, G. (2010) · Nature Biotechnology · doi:10.1038/nbt.1630 · Cited by 4,502
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · cited 2×
“The genes associated with SEs in cancer are enriched for drivers of oncogenic state as well as normal regulators of cell identity (Lovén et al., 2013; Hnisz et al., 2013).”
BackgroundSelective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Ostrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov189 · Cited by 2,139
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C.-W., Hopf, C., Savitski, M. M., et al. (2011) · Nature · doi:10.1038/nature10509 · Cited by 1,503
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Lewis, P. W., Müller, M. M., Koletsky, M. S., Cordero, F., Lin, S., Banaszynski, L. A., Garcia, B. A., Muir, T. W., Becher, O. J., & Allis, C. D. (2013) · Science · doi:10.1126/science.1232245 · Cited by 1,345
Jang, M. K., Mochizuki, K., Zhou, M., Jeong, H.-S., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,291
Targeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,243
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,110
Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028
Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion
Venkatesh, H. S., Johung, T. B., Caretti, V., Noll, A., Tang, Y., Nagaraja, S., Gibson, E. M., Mount, C. W., Polepalli, J., Mitra, S. S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.012 · Cited by 963
Self-citationTargeting transcription regulation in cancer with a covalent CDK7 inhibitor
Kwiatkowski, N., Zhang, T., Rahl, P. B., Abraham, B. J., Reddy, J., Ficarro, S. B., Dastur, A., Amzallag, A., Ramaswamy, S., Tesar, B., et al. (2014) · Nature · doi:10.1038/nature13393 · Cited by 855
Bender, S., Tang, Y., Lindroth, A. M., Hovestadt, V., Jones, D. T. W., Kool, M., Zapatka, M., Northcott, P. A., Sturm, D., Wang, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.006 · Cited by 818
Self-citationChresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1751 · Cited by 812
PANTHER version 10: expanded protein families and functions, and analysis tools
Mi, H., Poudel, S., Muruganujan, A., Casagrande, J. T., & Thomas, P. D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1194 · Cited by 770
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Chan, K.-M., Fang, D., Gan, H., Hashizume, R., Yu, C., Schroeder, M., Gupta, N., Mueller, S., James, C. D., Jenkins, R., et al. (2013) · Genes & Development · doi:10.1101/gad.217778.113 · Cited by 707
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
Grasso, C. S., Tang, Y., Truffaux, N., Berlow, N. E., Liu, L., Debily, M.-A., Quist, M. J., Davis, L. E., Huang, E. C., Woo, P. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3855 · Cited by 687
Self-citationThe Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation
Wu, S.-Y., & Chiang, C.-M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700001200 · Cited by 679
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0070 · Cited by 676
Self-citationA novel cyclin associates with M015/CDK7 to form the CDK-activating kinase
Fisher, R. P., & Morgan, D. O. (1994) · Cell · doi:10.1016/0092-8674(94)90535-5 · Cited by 655
Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., et al. (2014) · Nature Genetics · doi:10.1038/ng.2936 · Cited by 647
Self-citationCDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Chipumuro, E., Marco, E., Christensen, C. L., Kwiatkowski, N., Zhang, T., Hatheway, C. M., Abraham, B. J., Sharma, B., Yeung, C., Altabef, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.024 · Cited by 631
Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01341-10 · Cited by 532
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Taylor, K. R., Mackay, A., Truffaux, N., Butterfield, Y. S., Morozova, O., Philippe, C., Castel, D., Grasso, C. S., Vinci, M., Carvalho, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2925 · Cited by 517
Self-citationPharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Hashizume, R., Andor, N., Ihara, Y., Lerner, R., Gan, H., Chen, X., Fang, D., Huang, X., Tom, M. W., Ngo, V., et al. (2014) · Nature Medicine · doi:10.1038/nm.3716 · Cited by 476
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Wang, Y., Zhang, T., Kwiatkowski, N., Abraham, B. J., Lee, T. I., Xie, S., Yuzugullu, H., Von, T., Li, H., Lin, Z., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.063 · Cited by 465
mTORC1 and mTORC2 in cancer and the tumor microenvironment
Kim, L. C., Cook, R. S., & Chen, J. (2017) · Oncogene · doi:10.1038/onc.2016.363 · Cited by 444
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Christensen, C. L., Kwiatkowski, N., Abraham, B. J., Carretero, J., Al-Shahrour, F., Zhang, T., Chipumuro, E., Herter-Sprie, G. S., Akbay, E. A., Altabef, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.019 · Cited by 439
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation
Funato, K., Major, T., Lewis, P. W., Allis, C. D., & Tabar, V. (2014) · Science · doi:10.1126/science.1253799 · Cited by 390
Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II
Larochelle, S., Amat, R., Glover-Cutter, K., Sansó, M., Zhang, C., Allen, J. J., Shokat, K. M., Bentley, D. L., & Fisher, R. P. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2399 · Cited by 390
Molecular neurobiology of mTOR
Switon, K., Kotulska, K., Janusz-Kaminska, A., Zmorzynska, J., & Jaworski, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.017 · Cited by 387
The Double Bromodomain Proteins Brd2 and Brd3 Couple Histone Acetylation to Transcription
LeRoy, G., Rickards, B., & Flint, S. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.01.018 · Cited by 372
Association of Cdk-activating kinase subunits with transcription factor TFIIH
Serizawa, H., Mäkelä, T. P., Conaway, J. W., Conaway, R. C., Weinberg, R. A., & Young, R. A. (1995) · Nature · doi:10.1038/374280a0 · Cited by 367
Glover-Cutter, K., Larochelle, S., Erickson, B., Zhang, C., Shokat, K., Fisher, R. P., & Bentley, D. L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00637-09 · Cited by 350
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., Masek, M., Attema, J. L., Li, G., Haddix, T., Edwards, M. S. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101657108 · Cited by 348
Self-citationTargeting potassium channels in cancer
Huang, X., & Jan, L. Y. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201404136 · Cited by 330
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Tang, Y., Gholamin, S., Schubert, S., Willardson, M. I., Lee, A., Bandopadhayay, P., Bergthold, G., Masoud, S., Nguyen, B., Vue, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3613 · Cited by 314
Self-citationMirguet, O., Gosmini, R., Toum, J., Clément, C. A., Barnathan, M., Brusq, J.-M., Mordaunt, J. E., Grimes, R. M., Crowe, M., Pineau, O., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401088k · Cited by 305
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
Coudé, M.-M., Braun, T., Berrou, J., Dupont, M., Bertrand, S., Masse, A., Raffoux, E., Itzykson, R., Delord, M., Riveiro, M. E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4131 · Cited by 274
Larochelle, S., Merrick, K. A., Terret, M.-E., Wohlbold, L., Barboza, N. M., Zhang, C., Shokat, K. M., Jallepalli, P. V., & Fisher, R. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.003 · Cited by 268
Ninjurin, a Novel Adhesion Molecule, Is Induced by Nerve Injury and Promotes Axonal Growth
Araki, T., & Milbrandt, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80166-x · Cited by 263
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
Paugh, B. S., Zhu, X., Qu, C., Endersby, R., Diaz, A. K., Zhang, J., Bax, D. A., Carvalho, D., Reis, R. M., Onar-Thomas, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1491 · Cited by 235
Venneti, S., Garimella, M. T., Sullivan, L. M., Martinez, D., Huse, J. T., Heguy, A., Santi, M., Thompson, C. B., & Judkins, A. R. (2013) · Brain Pathology · doi:10.1111/bpa.12042 · Cited by 235
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Picaud, S., Fedorov, O., Thanasopoulou, A., Leonards, K., Jones, K., Meier, J., Olzscha, H., Monteiro, O., Martin, S., Philpott, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0236 · Cited by 229
Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Vinci, M., Box, C., & Eccles, S. A. (2015) · Journal of Visualized Experiments · doi:10.3791/52686 · Cited by 213
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
Jiang, Y.-Y., Lin, D.-C., Mayakonda, A., Hazawa, M., Ding, L.-W., Chien, W.-W., Xu, L., Chen, Y., Xiao, J.-F., Senapedis, W., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311818 · Cited by 212
Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling
Herz, H.-M., Morgan, M., Gao, X., Jackson, J., Rickels, R., Swanson, S. K., Florens, L., Washburn, M. P., Eissenberg, J. C., & Shilatifard, A. (2014) · Science · doi:10.1126/science.1255104 · Cited by 199
Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH
Rossignol, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1628 · Cited by 198
Hennika, T., Hu, G., Olaciregui, N. G., Barton, K. L., Ehteda, A., Chitranjan, A., Chang, C., Gifford, A. J., Tsoli, M., Ziegler, D. S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169485 · Cited by 191
Miao, H., Gale, N. W., Guo, H., Qian, J., Petty, A., Kaspar, J., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G., Hambardzumyan, D., et al. (2015) · Oncogene · doi:10.1038/onc.2013.590 · Cited by 174
The Phosphorylation of EphB2 Receptor Regulates Migration and Invasion of Human Glioma Cells
Nakada, M., Niska, J. A., Miyamori, H., McDonough, W. S., Wu, J., Sato, H., & Berens, M. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3667 · Cited by 174
Ephrin regulation of synapse formation, function and plasticity
Hruska, M., & Dalva, M. B. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.03.004 · Cited by 165
McCubrey, J. A., Rakus, D., Gizak, A., Steelman, L. S., Abrams, S. L., Lertpiriyapong, K., Fitzgerald, T. L., Yang, L. V., Montalto, G., Cervello, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.004 · Cited by 161
Cornichon proteins determine the subunit composition of synaptic AMPA receptors
Herring, B. E., Shi, Y., Suh, Y. H., Zheng, C.-Y., Blankenship, S. M., Roche, K. W., & Nicoll, R. A. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.017 · Cited by 155
Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1
Nakada, M., Drake, K. L., Nakada, S., Niska, J. A., & Berens, M. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4211 · Cited by 130
Shahbazi, J., Liu, P. Y., Atmadibrata, B., Bradner, J. E., Marshall, G. M., Lock, R. B., & Liu, T. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1666 · Cited by 122
Maes, T., Barceló, A., & Buesa, C. (2002) · Genomics · doi:10.1006/geno.2002.6799 · Cited by 115
Mechanism of Homophilic Binding Mediated by Ninjurin, a Novel Widely Expressed Adhesion Molecule
Araki, T., Zimonjic, D. B., Popescu, N. C., & Milbrandt, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21373 · Cited by 115
Ephrin reverse signaling in axon guidance and synaptogenesis
Xu, N., & Henkemeyer, M. J. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.10.024 · Cited by 113
Brown, Z. Z., Müller, M. M., Jain, S. U., Allis, C. D., Lewis, P. W., & Muir, T. W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5060934 · Cited by 111
Strategically targeting MYC in cancer
Posternak, V., & Cole, M. D. (2016) · F1000Research · doi:10.12688/f1000research.7879.1 · Cited by 111
Tumor Spheroid-Based Migration Assays for Evaluation of Therapeutic Agents
Vinci, M., Box, C., Zimmermann, M., & Eccles, S. A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-311-4_16 · Cited by 108
Gessi, M., Gielen, G. H., Dreschmann, V., Waha, A., & Pietsch, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1463-7 · Cited by 108
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
Zhang, Z., Ma, P., Jing, Y., Yan, Y., Cai, M., Zhang, M., Zhang, S., Peng, H., Ji, Z., Di, W. J., et al. (2015) · Theranostics · doi:10.7150/thno.13178 · Cited by 104
Subventricular spread of diffuse intrinsic pontine glioma
Caretti, V., Bugiani, M., Freret, M. E., Schellen, P., Jansen, M. H. A., van Vuurden, D. G., Kaspers, G. J. L., Fisher, P. G., Hulleman, E., Wesseling, P., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1307-x · Cited by 101
Self-citationHashizume, R., Smirnov, I. V., Liu, S., Phillips, J. J., Hyer, J. D., McKnight, T. R., Wendland, M. F., Prados, M. D., Banerjee, A., Nicolaides, T. P., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0973-6 · Cited by 99
Selected SALM (Synaptic Adhesion-Like Molecule) Family Proteins Regulate Synapse Formation
Mah, W., Ko, J., Nam, J., Han, K., Chung, W., & Kim, E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4839-09.2010 · Cited by 98
EAG2 potassium channel with evolutionarily conserved function as a brain tumor target
Huang, X., He, Y., Dubuc, A. M., Hashizume, R., Zhang, W., Reimand, J., Yang, H., Wang, T. A., Stehbens, S. J., Younger, S. H., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4088 · Cited by 97
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Bid, H. K., Phelps, D. A., Xaio, L., Guttridge, D. C., Lin, J., London, C. A., Baker, L. H., Mo, X. M., & Houghton, P. J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0567 · Cited by 92
Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development
Maier, V., Jolicoeur, C., Rayburn, H., Takegahara, N., Kumanogoh, A., Kikutani, H., Tessier‐Lavigne, M., Wurst, W., & Friedel, R. H. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.11.005 · Cited by 91
Sengupta, D., Kannan, A., Kern, M., Moreno, M. A., Vural, E. A., Stack, B. C., Suen, J. Y., Tackett, A. J., & Gao, L. (2015) · Epigenetics · doi:10.1080/15592294.2015.1034416 · Cited by 87
Mouse Neuron navigator 1, a novel microtubule-associated protein involved in neuronal migration
Martínez-López, M. J., Alcántara, S., Mascaró, C., Pérez‐Brangulí, F., Ruiz‐Lozano, P., Maes, T., Soriano, E., & Buesa, C. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.09.016 · Cited by 85
Eph-ephrin signaling in nervous system development
Cramer, K. S., & Miko, I. J. (2016) · F1000Research · doi:10.12688/f1000research.7417.1 · Cited by 84
Targeting transcription factors by small compounds—Current strategies and future implications
Hagenbuchner, J., & Ausserlechner, M. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.12.006 · Cited by 81
Taylor, I. C., Hütt-Cabezas, M., Brandt, W. D., Kambhampati, M., Nazarian, J., Chang, H. T., Warren, K. E., Eberhart, C. G., & Raabe, E. H. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000216 · Cited by 80
Shankar, G. M., Lelic, N., Gill, C. M., Thorner, A. R., Hummelen, P. V., Wisoff, J. H., Loeffler, J. S., Brastianos, P. K., Shin, J. H., Borges, L. F., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1492-2 · Cited by 74
Sun, H., Luo, L., Lal, B., Ma, X., Chen, L., Hann, C. L., Fulton, A. M., Leahy, D. J., Laterra, J., & Li, M. (2016) · Nature Communications · doi:10.1038/ncomms10339 · Cited by 69
Self-citationPatch-clamp analysis : advanced techniques
Walz, W., Boulton, A. A., & Baker, G. B. (2002) · Cited by 62
Postnatal growth of the human pons: A morphometric and immunohistochemical analysis
Tate, M. C., Lindquist, R. A., Nguyen, T. M., Sanai, N., Barkovich, A. J., Huang, E. J., Rowitch, D. H., & Álvarez-Buylla, A. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23690 · Cited by 54
Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?
Cristea, S., & Sage, J. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.04.018 · Cited by 52
Sengupta, S., Biarnes, M. C., Clarke, R. C., & Jordan, V. C. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3319-1 · Cited by 41
Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors
Qiao, L., Choi, S., Case, A. W., Gainer, T. G., Seyb, K. I., Glicksman, M. A., Lo, D. C., Stein, R. L., & Cuny, G. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.010 · Cited by 33
Identification of Domains and Amino Acids Involved in GluR7 Ion Channel Function
Strutz, N., Villmann, C., Thalhammer, A., Kizelsztein, P., Eisenstein, M., Teichberg, V. I., & Hollmann, M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00401.2001 · Cited by 18
Cited by
c-Jun overexpression in CAR T cells induces exhaustion resistance
Lynn, R. C., Weber, E. W., Sotillo, E., Gennert, D., Xu, P., Good, Z., Anbunathan, H., Lattin, J., Jones, R., Tieu, V., et al. (2019) · Nature · doi:10.1038/s41586-019-1805-z · Cited by 891
Self-citationEpigenetics in health and disease
Zhang, L., Lu, Q., & Chang, C. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3449-2_1 · Cited by 689
Self-citationTargeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma
Venkatesh, H. S., Tam, L. T., Woo, P. J., Lennon, J., Nagaraja, S., Gillespie, S. M., Ni, J., Duveau, D. Y., Morris, P. J., Zhao, J. J., et al. (2017) · Nature · doi:10.1038/nature24014 · Cited by 602
Self-citationWeller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00516-y · Cited by 592
Self-citationGlioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Gimple, R. C., Bhargava, S., Dixit, D., & Rich, J. N. (2019) · Genes & Development · doi:10.1101/gad.324301.119 · Cited by 514
Metadata
- Authors
- Nagaraja, S., Vitanza, N. A., Woo, P. J., Taylor, K. R., Liu, F., Zhang, L., Li, M., Meng, W., Ponnuswami, A., Sun, W., Ma, J., Hulleman, E., Swigut, T., Wysocka, J., Tang, Y., & Monje, M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 31
- Issue
- 5
- Pages
- 635-652.e6
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2606835938
- Cited by
- 396
- References
- 97
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.